Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Lancet Neurol 16:465477
On July 10, 2024, Kuei-Pin Huang and colleagues published a paper in Nature titled Dissociable Hindbrain GLP1R Circuits for Satiety and Aversion. The study suggests that future weight loss medications could selectively target GLP1R neurons in the nucleus of the solitary tract (NTS) to avoid inducing aversion, thereby improving treatment adherence and effectiveness [1]
.png?sfvrsn=f94c669f_5)
How does GLP-1 medication affect the gut
Where decisions were uncertain, Dr Spriet consulted with the Editor-in-Chief
Parametric and nonparametric tests were used for the analysis of qualitative variables
Learn how GLP-1 is reshaping FMCG demand To view or add a comment, sign in More Relevant Posts GLP-1 use is rebalancing entire shopping baskets
US$ 28.88
US$ 22.43
US$ 24.18
US$ 23.97
